|19.36||+0.1800||+0.94%||Vol 491.56K||1Y Perf -25.97%|
|Aug 5th, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||28.33||Analyst Rating||Moderate Buy 2.00|
|Potential %||46.33||Finscreener Ranking||★★★★+ 56.33|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★★ 56.23|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★★ 70.31|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||34.73||Earnings Rating||Neutral|
|Market Cap||1.20B||Earnings Date||14th Sep 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||14th Sep 2022|
|Estimated EPS Next Report||0.03|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||552.50K|
|Avg. Monthly Volume||619.86K|
|Avg. Quarterly Volume||657.03K|
Avid Bioservices Inc. (NASDAQ: CDMO) stock closed at 19.36 per share at the end of the most recent trading day (a 0.94% change compared to the prior day closing price) with a volume of 491.56K shares and market capitalization of 1.20B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 227 people. Avid Bioservices Inc. CEO is Nicholas S. Green.
The one-year performance of Avid Bioservices Inc. stock is -25.97%, while year-to-date (YTD) performance is -33.65%. CDMO stock has a five-year performance of 396.41%. Its 52-week range is between 11.3 and 34.51, which gives CDMO stock a 52-week price range ratio of 34.73%
Avid Bioservices Inc. currently has a PE ratio of 9.80, a price-to-book (PB) ratio of 6.41, a price-to-sale (PS) ratio of 8.95, a price to cashflow ratio of 134.80, a PEG ratio of 2.32, a ROA of 38.53%, a ROC of 6.78% and a ROE of 105.20%. The company’s profit margin is 13.66%, its EBITDA margin is 18.40%, and its revenue ttm is $119.60 Million , which makes it $1.93 revenue per share.
Of the last four earnings reports from Avid Bioservices Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.03 for the next earnings report. Avid Bioservices Inc.’s next earnings report date is 14th Sep 2022.
The consensus rating of Wall Street analysts for Avid Bioservices Inc. is Moderate Buy (2), with a target price of $28.33, which is +46.33% compared to the current price. The earnings rating for Avid Bioservices Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Avid Bioservices Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Avid Bioservices Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 20.77, ATR14 : 1.47, CCI20 : 55.92, Chaikin Money Flow : 0.06, MACD : 0.83, Money Flow Index : 51.77, ROC : 1.89, RSI : 31.85, STOCH (14,3) : 71.02, STOCH RSI : 1.00, UO : 48.42, Williams %R : -28.98), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Avid Bioservices Inc. in the last 12-months were: Catherine J. Mackey (Option Excercise at a value of $0), Daniel Ryan Hart (Option Excercise at a value of $2 830), Daniel Ryan Hart (Sold 11 337 shares of value $213 464 ), Esther Alegria (Option Excercise at a value of $0), Gregory P. Sargen (Option Excercise at a value of $0), Joseph Carleone (Option Excercise at a value of $0), Mark R. Ziebell (Option Excercise at a value of $348 075), Mark R. Ziebell (Sold 47 858 shares of value $1 242 435 ), Nicholas S. Green (Option Excercise at a value of $0), Nicholas S. Green (Sold 34 603 shares of value $636 824 ), Richard B. Hancock (Option Excercise at a value of $138 591), Richard B. Hancock (Sold 40 000 shares of value $840 076 )
Thu, 10 Mar 2022 01:45 GMT Analysts Offer Insights on Healthcare Companies: Avid Bioservices (CDMO) and Corbus Pharmaceuticals (CRBP)- TipRanks. All rights reserved.
Wed, 09 Mar 2022 12:30 GMT Analysts Offer Insights on Healthcare Companies: Avid Bioservices (CDMO) and PROCEPT BioRobotics (PRCT)- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.